Risk factor | Number of included literature | Results of heterogeneity test | Effect model | Result | |
---|---|---|---|---|---|
I2 | Â | OR (95%CI) | p | ||
Zidovudine (2,10) | 2 | 85.5% | Random effect model | 9.28 [1.18–73] |  < 0.05* |
Stunting (4,22) | 2 | 30.3% | Random effect model | 2.36 (1.54–3.62) |  < 0.001* |
Rural (4,38) | 2 | 96.4% | Random effect model | 3.1 (0.22–43.64) | 0.401 |
Low CD4 Count (2,5,19,20,22,26,30,38) | 8 | 45% | Random effect model | 3.56 (2.59–4.9) |  < 0.001* |
Underweight BMI (5,26) | 2 | 0% | Fixed effect model | 4.75 [3.57–6.33] |  < 0.05* |
Female Gender (5,20,28,30) | 4 | 11% | Fixed effect model | 3.06 (2.71- 3.45) |  < 0.05* |
Viral Load (16, 22) | 2 | 0.0% | Fixed effect model | 2.86 (1.47–5.58) |  < 0.05* |
Low WBC (25, 38) | 2 | 0% | Fixed effect model | 3.67 (0.92–14.63) | 0.0531 |
Before ART_ (30,38) | 2 | 72.7% | Random effect model | 2.67 (1.17–6.12) |  < 0.05* |
HIV Stage 3 & 4 | 2 | 0% | Fixed effect model | 1.42(0.64–3.15) | 0.376 |
Alcohol | 2 | 0% | Fixed effect model | 0.85(0.47–1.56) | 0.605 |
Smoking | 2 | 41% | Random effect model | 0.99(0.44–2.22) | 0.995 |
Opportunistic Infections | 4 | 46% | Random effect model | 2.19(1.07–4.5) |  < 0.05* |